论文发表

  累积发表SCI/EI期刊47篇，以第一作者（含共一）或通讯作者发表IF>10或细分领域Q1区顶级期刊34篇，1篇论文入选ESI热点论文（Top 0.1%），6篇论文入选ESI高被引论文（Top 1%），H指数26，累计影响因子超过500。

 

  • 2024年度

  1. He W*, Wang Y, Li X, Ji Y, Yuan J, Yang W, Yan S, Yan J*. Sealing the Pandora’s vase of pancreatic fistula through entrapping the digestive enzymes within a dextrorotary (D)-peptide hydrogel. Nature Communications. 2024, 15 (1): 7235. IF= 14.7

  2. Liu D#, Yan J#,*, Ma F, Wang J, Yan S, He W*. Reinvigoration of cytotoxic T lymphocytes in microsatellite instability-high colon adenocarcinoma through lysosomal degradation of PD-L1. Nature Communications. 2024, 15(1): 6922. IF= 14.7

  3. Liu N#, Zheng X#, Yan J#, Jiang A, Yao Y, He W. Reversing MET‐mediated resistance in oncogene‐driven NSCLC by MET‐activated Wnt condensative prodrug. Advanced Science. 2024, 11: 2400603. IF= 14.3

  4. Yang W#, Li Z#, Li Y, He W*, Yan J*. Transforming Albumin into a Trojan Horse of Immunotherapy-Resistant Colorectal Cancer with a High Microsatellite Instability. ACS Nano. 2024, 18(29): 19332–19344. IF= 15.8

  5. Li X#, Wang Y#, Yuan J#, An J, Yan S, Wu W, He W*, Yan J*, Tao K*. Chiral D-peptide supramolecular hydrogel for minimizing postoperative pancreatic fistula by devitalizing pancreatic enzymes. Chemical Engineering Journal. 2024, 482: 149069. IF= 13.3

  6. Jiang A, Zheng X, Yan S, Yan J*, Yao Y*, He W*. Advancing the boundares of immunotherapy in lung adenocarcinoma withidiopathic pulmonary fibrosis by a biomimetic proteinoid enabling selective endocytosis. ACS Nano. 2024, 18(7): 5358-5373. IF= 15.8

  7. Yan J#,*, Liu D#, Wang J, You W, Yang W, Yan S, He W*. Rewiring chaperone-mediated autophagy in cancer by a prion-like chemical inducer of proximity to counteract adaptive immune resistance. Drug Resistance Updates. 2024, 73: 101037. IF= 15.8/24.3 ESI热点论文（Top 0.1%）

  • 2023年度

  1. Wang J#, Zhao J#, Ma F, Gong L, Lu Y, Xiao W, Tang H, Gao C, Chen Y, Ma J, Gao Z, Yan J*, Han S*. One stone, two birds: A peptide‐Au (I) infinite coordination supermolecule for the confederate physical and biological radiosensitization in cancer radiation therapy. Small, 2023: 19(11): 2204238. IF= 13.0

  2. Yang W#, Liu W#,*, Li X#, Yan J*, He W*. Turning chiral peptides into a racemic supraparticle to induce the self-degradation of MDM2. Journal of Advanced Research. 2023, 45: 59-71. IF= 11.4 ESI高被引论文（Top 1%）

  3. Zhou Z#, Li X#, Yang G#,*, Wang J, Li B, Huang Y*, Yan J*, Tao K*. Targeting β-catenin and PD-L1 simultaneously by a racemic supramolecular peptide for the potent immunotherapy of hepatocellular carcinoma. Theranostics. 2023, 13(10): 3371–3386. IF= 12.4

  4. Yuan J#, Wang Y#, Yang W#, Li X, Tao K, He W*, Yan J*. Biomimetic peptide dynamic hydrogel inspired by humanized defensin nanonets as the wound-healing gel coating. Chemical Engineering Journal. 2023, 470: 144266. IF= 13.3

  • 2022年度

  1. Liu T#, Yan J#, He C#, You W, Ma F, Chang Z, Li Y, Han S*, He W*, Liu W*. A tumor-targeting metal-organic nanoparticle constructed by dynamic combinatorial chemistry toward accurately redressing carcinogenic Wnt cascade. Small. 2022, 18(3): 2104849. IF= 13.0

  2. Li L#，He W#,*, You W, Yan J*, Liu W*. Turing miRNA into infinite coordination supermolecule: a general and enabling nanoengineering strategy for resurrecting nuclear acid therapeutics. Journal of Nanobiotechnology. 2022, 20(10): 1-15. IF= 10.6 ESI高被引论文（Top 1%）

  3. Yan J*, Zheng X, You W, He W*, Xu G*. A bionic-homodimerization strategy for optimizing modulators of protein–protein interactions: from statistical mechanics theory to potential clinical translation. Advanced Science. 2022, 9(11): 2105179. IF=14.3 ESI高被引论文（Top 1%）

  4. He W#,*, Zhang Z#, Yang W, Zheng X, You W, Yao Y, Yan J*, Liu W*. Turing milk into pro-apoptotic oral nanotherapeutic: De novo bionic chiral-peptide supramolecule for cancer targeted and immunological therapy. Theranostics. 2022,12(5):2322-2334. IF= 12.4

  5. Ma F#, Liu T#, Yang W#, You W, He W*, Yan J*, Liu W*. Turning Fluvastatin into a supramolecular immuno-sensitizer towards augmented tumor immunotherapy. Chemical Engineering Journal. 2022,437:135310. IF= 13.3

  6. Yan J#, Zhang L#, Li L, He W*, Liu W*. Developmentally engineered bio-assemblies releasing neurotrophic exosomes guide in situ neuroplasticity following spinal cord injury. Materials Today Bio. 2022,16:100406. IF= 8.7

  7. Wang Y#, Li X#, Yuan J, Wang X, Tao K*, Yan J*. A Bionic self-assembly hydrogel constructed by peptides with favorable biosecurity, rapid hemostasis and antibacterial property for wound healing[J]. Frontiers in bioengineering and biotechnology. 2022,10:901534-901534. IF= 4.3

  8. You W, Ma F, Zhang Z*, Yan J*. Turning a targeting β-catenin/Bcl9 peptide inhibitor into a GdOF@ Au core/shell nanoflower for enhancing immune response to cancer therapy in combination with immune checkpoint inhibitors[J]. Pharmaceutics, 2022, 14(6): 1306. IF= 4.9

  • 2021年度

  1. Yan J#,*, He W#,*, Li X#, You W, Liu X, Lin S, Chen J, Zhao Y, Zhang Y*, Ji F*. Carnosic acid-induced co-self-assembly of metal-peptide complexes into a nanocluster-based framework with tumor-specific accumulation for augmented immunotherapy. Chemical Engineering Journal. 2021, 416: 129141. IF=13.3  

  2. Zheng X#, Yan J#,*, You W, Li F, Diao J, He W*, Yao Y*. De novo nano-erythrocyte structurally braced by biomimetic Au(I)-peptide skeleton for MDM2/MDMX predation toward augmented pulmonary adenocarcinoma immunotherapy. Small. 2021, 17(20): 2100394. IF=13.0

  3. Yan S#, Yan J#,*, Liu D#, Li X#, Kang Q, You W, Zhang J, Wang L, Tian Z, Lu W*, Liu W*, He W*. A nano-predator of pathological MDMX construct by clearable supramolecular gold(I)-thiol-peptide complexes achieves safe and potent anti-tumor activity. Theranostics. 2021, 11(14): 6833-6846. IF=12.4 ESI高被引论文（Top 1%）

  4. Yan J#,*, Wang Y#, Li X#, Guo D, Zhou Z, Bai G, Li J, Huang N, Diao J, Li Y, He W*, Liu W*, Tao K*. A bionic nano-band-aid constructed by the three-stage self-assembly of peptides for rapid liver hemostasis. Nano Letters. 2021, 21(17): 7166-7174. IF= 9.6 

  • 2020年度

  1. Yan J#, Ji F#, Yan S#, You W, Ma F, Li F, Huang Y*, Liu W*, He W*. A general-purpose Nanohybrid fabricated by Polymeric Au(I)-peptide precursor to wake the function of Peptide Therapeutics. Theranostics. 2020, 10(19): 8513-8527. IF=12.4

  2. He W#, Yan J#,*, Li Y#, Yan S, Wang S, Hou P*, Lu W*. Resurrecting a p53 peptide activator - An enabling nanoengineering strategy for peptide therapeutics. Journal of Controlled Release. 2020, 325: 293-303. IF= 10.5

  3. She J#,*, Li Y#, Yan S, Yan Y, Liu D, Li S, Guo Y, Xue Y, Yao Y, Yan J*, He W*. De novo supraparticle construction by a self-assembled Janus cyclopeptide to tame hydrophilic microRNA and hydrophobic molecule for anti-tumor cocktail therapy and augmented immunity. Chemical Engineering Journal. 2020, 401: 126080. IF=13.3

  4. Yan J#,*, Yao Y#, Yan S, Gao R, Lu W*, He W*. Chiral protein supraparticles for tumor suppression and synergistic immunotherapy: an enabling strategy for bioactive supramolecular chirality construction. Nano Letters. 2020, 20(8): 5844-5852. IF= 9.6 ESI高被引论文（Top 1%）

  • 2019年度

  1. He W#, Wang S#, Yan J#, Qu Y, Jin L, Sui F, Li Y, You W, Yang G, Yang Q, Ji M, Shao Y, Ma PX*, Lu W*, Hou P*. Self-assembly of therapeutic peptide into stimuli-responsive clustered nanohybrids for cancer-targeted therapy. Advanced Functional Materials. 2019, 29(10): 1807736. IF=18.5

  2. He W#, Yan J#, Wang L#, Lei B, Hou P*, Lu W*, Ma PX*. A lanthanide-peptide-derived bacterium-like nanotheranostic with high tumor-targeting, -imaging and -killing properties. Biomaterials. 2019, 206: 13-24. IF= 12.8

  3. Yan J, Yan S, Hou P, Lu W, Ma PX, He W*, Lei B*. A hierarchical peptide–lanthanide framework to accurately redress intracellular carcinogenic protein–protein interaction. Nano Letters. 2019, 19(11): 7918-7926. IF= 9.6

  4. Liu J#, Yan J#,*, Yan S#, Wang Y, Zhang R, Hou P, He W*, Ji M*. Biomimetic and self-assembled nanoclusters targeting β-catenin for potent anticancer therapy and enhanced immunotherapy. Nano Letters. 2019, 19(12): 8708-8715. IF= 9.6

  • 2018年度

  1. Bian Z#, Yan J#, Wang S#, Li Y, Guo Y, Ma B, Guo H, Lei Z, Yin C, Zhou Y, Liu M, Tao K*, Hou P*, He W*. Awakening p53 in vivo by D-peptides-functionalized ultra-small nanoparticles: Overcoming biological barriers to D-peptide drug delivery. Theranostics. 2018, 8(19): 5320-5335. IF=12.4

  2. Yan J#, He W#,*, Yan S#, Niu F, Liu T, Ma B, Shao Y, Yan Y, Yang G, Lu W, Du Y, Lei B*, Ma PX. Self-assembled peptide-lanthanide nanoclusters for safe tumor therapy: overcoming and utilizing biological barriers to peptide drug delivery. ACS Nano. 2018, 12(2): 2017-2026. IF= 15.8 ESI高被引论文（Top 1%）

  3. Niu F#, Yan J#, Ma B, Li S, Shao Y, He P, Zhang W, He W*, Ma PX*, Lu W*. Lanthanide-doped nanoparticles conjugated with an anti-CD33 antibody and a p53-activating peptide for acute myeloid leukemia therapy. Biomaterials. 2018, 167: 132-142. IF= 12.8

  4. He W#, Yan J#, Jiang W#, Li S, Qu Y, Niu F, Yan Y, Sui F, Wang S, Zhou Y, Jin L, Li Y, Ji M, Ma PX, Liu M*, Lu W*, Hou P*. Peptide-induced self-assembly of therapeutics into a well-defined nanoshell with tumor-triggered shape and charge switch. Chemistry of Materials. 2018, 30(20): 7034-7046. IF= 7.2

  5. He W#,*, Yan J#, Sui F#, Wang S, Su X, Qu Y, Yang Q, Guo H, Ji M, Lu W, Shao Y*, Hou P*. Turning a luffa protein into a self-assembled biodegradable nanoplatform for multitargeted cancer therapy. ACS Nano. 2018, 12(11): 11664-11677. IF= 15.8

  • ​​​​​​​2017以前

  1. ​​​​​​​Yan J#, He W#, Li N, Yu M, Du Y, Lei B*, Ma PX*. Simultaneously targeted imaging cytoplasm and nucleus in living cell by biomolecules capped ultra-small GdOF nanocrystals. Biomaterials. 2015, 59: 21-29. IF= 12.8